Back to search

Article

Exploring real-world user experiences of GLP-1 receptor agonist therapy for obesity treatment, and barriers and motivators to adherence

2025-12-12

Abstract excerpt

<h4>Background</h4> Glucagon-like peptide-1 receptor agonists (GLP-1RAs) demonstrate efficacy for weight loss in clinical trials, yet real-world implementation challenges remain poorly understood. This study evaluated current and former user experiences of GLP-1RA medications for obesity treatment in the UK. <h4>Methods</h4> A cross-sectional online survey was administered via Prolific to 352 current and 272 for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9da220d-607d-5ca8-bed5-da0287c0e667
DOI
10.64898/2025.12.11.25342052
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring real-world user experiences of GLP-1 receptor agonist therapy for obesity treatment, and barriers and motivators to adherenceDOI 10.64898/2025.12.11.25342052
Real-World Weight Loss and Telehealth Platform Utilization Patterns of Long-Term GLP-1 Receptor Agonist Treatment of self pay patients : A Retrospective AnalysisSemantic proximity
Patient Adherence to a Real-World Digital Asynchronous Weight-Loss Program in Australia That Combines Behavioural and GLP-1 RA Therapy: A Mixed Methods StudySemantic proximity
Twelve-month analysis of real-world evidence from a commercial telehealth obesity treatment providerSemantic proximity
Considering Real-World Effectiveness of GLP-1RA Persistence and Outcomes for Weight loss regimes.Semantic proximity
From Desperation to Sustainability: A Qualitative Exploration of Drivers and Barriers to Time-Restricted Eating in IBS TreatmentSemantic proximity
Current status of anti-obesity medications and performance, an EHR based surveySemantic proximity
Enhanced Patient Portal Engagement Associated with Improved Weight Loss Outcomes in Post-Bariatric Surgery PatientsSemantic proximity
Real-World Effectiveness, Safety, and Use Patterns of GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes: A Nationwide Multicentre Community Pharmacy StudySemantic proximity
Primary Care Obesity Management at the Threshold of the GLP-1 Era: A Survey-Based Change Readiness AssessmentSemantic proximity
Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online SurveySemantic proximity
Personalizing a Weight Loss Program Using Cognitive-Behavioral Phenotypes to Improve Engagement and Weight Loss in Adults With Overweight or Obesity: Quasi-Experimental Study.Semantic proximity
Understanding Suboptimal Insulin Use in Type 1 and 2 Diabetes: A Cross-sectional Survey of Healthcare Providers who Treat People With DiabetesSemantic proximity
Select a neighboring publication to make it the new centre.